Free Trial
NASDAQ:ASPI

ASP Isotopes Q2 2025 Earnings Report

ASP Isotopes logo
$6.64 +0.09 (+1.37%)
Closing price 04:00 PM Eastern
Extended Trading
$6.71 +0.07 (+0.99%)
As of 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ASP Isotopes EPS Results

Actual EPS
-$1.03
Consensus EPS
-$0.11
Beat/Miss
Missed by -$0.92
One Year Ago EPS
N/A

ASP Isotopes Revenue Results

Actual Revenue
$1.20 million
Expected Revenue
$1.60 million
Beat/Miss
Missed by -$400.00 thousand
YoY Revenue Growth
N/A

ASP Isotopes Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, August 14, 2025
Conference Call Time
7:00AM ET

Upcoming Earnings

ASP Isotopes' Q2 2026 earnings is estimated for Friday, August 14, 2026, based on past reporting schedules, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

ASP Isotopes Earnings Headlines

ASP Isotopes: The Long Road From Isotopes To Income
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of the profits are typically already gone. SpaceX insiders bought in at a $20 billion valuation - you're being offered entry at $1.75 trillion. But one small, publicly traded company sits directly in SpaceX's supply chain, still priced like Wall Street hasn't noticed. It powers critical infrastructure Musk's operation can't run without. Dylan Jovine is naming it today, free.tc pixel
See More ASP Isotopes Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ASP Isotopes? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ASP Isotopes and other key companies, straight to your email.

About ASP Isotopes

ASP Isotopes (NASDAQ:ASPI), a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

View ASP Isotopes Profile